Home › TATACONSUM › Filing
🔔 Get instant alerts when TATACONSUM files quarterly results on BSE Start free trial →

Press Release

Filed: 26 Oct 2026, 16:56 IST Exchange: NSE Category: Financial Results — Press Release
Press Release - Q2FY27 - Revenue 56.6bn +14% y-y; EBITDA 7.94bn +18% y-y; PAT 4.7bn +16% y-y - India branded business underlying volume growth 11%, led by strong salt volumes - Growth businesses grew 40%, now 38% of India business - Tata Sampann revenue +57%, RTD revenue +47% in Q2FY27 - International business revenue +7% (constant currency -2%) with UK and Canada mixed trends - Tata Starbucks revenue +15%, opened 7 new stores including 2 Reserve stores - Innovation drove growth with 22 new launches in Q2FY27 - MD: Focus on profitable scaling of core and growth businesses with AI-led digital transformation
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 TATACONSUM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add TATACONSUM to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Tata Consumer Products Ltd

Important. The summary above is generated automatically from Tata Consumer Products Ltd's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.